Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HCV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01795911
What this trial is testing

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 165
Large-scale testing (Phase 3)Study completedNCT01704755
What this trial is testing

Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie (prior sponsor, Abbott) 381
Testing effectiveness (Phase 2)Study completedNCT00227435
What this trial is testing

Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT02673489
What this trial is testing

Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 106
Large-scale testing (Phase 3)Study completedNCT01903278
What this trial is testing

Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis c
Beijing Kawin Technology Share-Holding Co., Ltd. 719
Early research (Phase 1)Study completedNCT01591668
What this trial is testing

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Gilead Sciences 51
Not applicableStudy completedNCT01464008
What this trial is testing

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Beijing Ditan Hospital 297
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Early research (Phase 1)Study completedNCT00591214
What this trial is testing

Safety and PK Study of MP-424 to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 10
Not applicableActive Not RecruitingNCT07565948
What this trial is testing

Sofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA Treatment

Who this might be right for
Hepatitis C Virus (HCV)
Xiangya Hospital of Central South University 200
Large-scale testing (Phase 3)Study completedNCT01783678
What this trial is testing

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Chronic Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 275
Testing effectiveness (Phase 2)Study completedNCT01563536
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 12
Not applicableStudy completedNCT02823457
What this trial is testing

VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C

Who this might be right for
Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders
G.V. (Sonny) Montgomery VA Medical Center 20
Not applicableEnded earlyNCT00705107
What this trial is testing

Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 267
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Not applicableLooking for participantsNCT07095192
What this trial is testing

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada

Who this might be right for
HCVHEPATITIS C VIRUS CHRONIC INFECTION
McGill University 300
Testing effectiveness (Phase 2)Study completedNCT01017575
What this trial is testing

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin)

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 55
Not applicableStudy completedNCT03341871
What this trial is testing

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 1,095
Large-scale testing (Phase 3)Study completedNCT01846832
What this trial is testing

TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection

Who this might be right for
Hepatitis C, ChronicInfection
Janssen-Cilag International NV 232
Large-scale testing (Phase 3)Study completedNCT00162734
What this trial is testing

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

Who this might be right for
Chronic Hepatitis C
Bausch Health Americas, Inc. 144
Next Page